The approach AXON is using is bound to fail. Check out AVXL for Alzheimer's and other nuerodegenerative diseases. Up over 25% today on Michael J Fox funded Parkinson's mouse study. It seems to be working in many different areas and is very safe.
Market Data 
Markets 
AI
